ABSTRACT NUMBER: ESOC2026A2026 IMPACT OF ENDOVASCULAR TREATMENT IN PATIENTS AGED ≥85 YEARS WITH LARGE VESSEL OCCLUSION ISCHEMIC STROKE

Abstract Background and aims To evaluate functional outcomes and mortality in patients aged ≥85 years with large vessel occlusion (LVO) ischemic stroke managed with endovascular therapy (EVT). Methods We conducted a prospective, multicenter observational study including patients aged ≥85 years with LVO treated in seven Stroke Centres in Madrid over one year (from February 2024). Patients treated with EVT were compared with those managed without EVT. Inverse probability of treatment weighting (IPTW) based on propensity scores was applied to adjust for baseline differences between groups. Results A total of 277 patients were included (71% women), with a mean age of 89.2 ± 3.11 years and a median baseline mRS of 1 (IQR 0–4). EVT was performed in 188 patients (67.8%). Patients treated with EVT had less pre-stroke cognitive impairment and higher NIHSS scores. After IPTW adjustment, there were no significant differences in functional independence at 3 months (mRS 0–2) between EVT and non-EVT patients (31.1% vs 24.7%; p = 0.31; OR = 1.41, 95% CI 0.72–2.72). However, EVT was associated with a higher proportion of favorable outcomes when considering the mRS 0–3 (50.0% vs 31.9%; p = 0.035; OR = 1.92, 95% CI 1.05–3.52) and with lower 3-month mortality (29.3% vs 50.9%; p = 0.038; OR = 0.51, 95% CI 0.27–0.96). Conclusions In our cohort, EVT did not significantly increase the likelihood of full independence or mild disability (mRS 0–2) at 3 months. However, EVT was associated with reduced mortality and a lower degree of disability among dependent patients. Conflict of interest A. Sánchez Asensio: nothing to disclose, C. Moreno López: nothing to disclose, P. González-Barquero: nothing to disclose, A.M. Iglesias Mohedano: nothing to disclose, M. Vales Montero: nothing to disclose, C. Gómez Escalonilla: nothing to disclose, P. Simal Hernández: nothing to disclose, L. Vidal Guerrero: nothing to disclose, J. Rodríguez Pardo De Donlebun: nothing to disclose, J. Alonso Maroto: nothing to disclose, S. Trillo Senin: nothing to disclose, M. Gutiérrez Sánchez De La Fuente: nothing to disclose, P. Calleja Castaño: nothing to disclose, R. Velasco Calvo: nothing to disclose, J. Carneado-Ruiz: nothing to disclose, A. Cruz Culebras: nothing to disclose, S. García Madrona: nothing to disclose, J. Masjuan Vallejo: nothing to disclose y R. Vera Lechuga: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.947
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A2026 IMPACT OF ENDOVASCULAR TREATMENT IN PATIENTS AGED ≥85 YEARS WITH LARGE VESSEL OCCLUSION ISCHEMIC STROKE

A. Iglesias Mohedano, Santiago Trillo Senín, Jaime Alonso, Rocío Velasco Calvo et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A2026 IMPACT OF ENDOVASCULAR TREATMENT IN PATIENTS AGED ≥85 YEARS WITH LARGE VESSEL OCCLUSION ISCHEMIC STROKE

A. Iglesias Mohedano, Santiago Trillo Senín, Jaime Alonso, Rocío Velasco Calvo, Antonio Culebras, C Pueyo López, Jorge Rodríguez-Pardo, Pilar González-Barquero, Patricia Simal Hernández, C. Escobar, Rocío Vera, Patricia Calleja Castaño, Sebastian García Madrona, Marta Vales Montero, Jaime Masjuan, Laura Vidal, Maria Gutiérrez Sánchez de la Fuente, Ana Sánchez Asensio, Joaquin Carneado-Ruiz
article en

Abstract

Abstract Background and aims To evaluate functional outcomes and mortality in patients aged ≥85 years with large vessel occlusion (LVO) ischemic stroke managed with endovascular therapy (EVT). Methods We conducted a prospective, multicenter observational study including patients aged ≥85 years with LVO treated in seven Stroke Centres in Madrid over one year (from February 2024). Patients treated with EVT were compared with those managed without EVT. Inverse probability of treatment weighting (IPTW) based on propensity scores was applied to adjust for baseline differences between groups. Results A total of 277 patients were included (71% women), with a mean age of 89.2 ± 3.11 years and a median baseline mRS of 1 (IQR 0–4). EVT was performed in 188 patients (67.8%). Patients treated with EVT had less pre-stroke cognitive impairment and higher NIHSS scores. After IPTW adjustment, there were no significant differences in functional independence at 3 months (mRS 0–2) between EVT and non-EVT patients (31.1% vs 24.7%; p = 0.31; OR = 1.41, 95% CI 0.72–2.72). However, EVT was associated with a higher proportion of favorable outcomes when considering the mRS 0–3 (50.0% vs 31.9%; p = 0.035; OR = 1.92, 95% CI 1.05–3.52) and with lower 3-month mortality (29.3% vs 50.9%; p = 0.038; OR = 0.51, 95% CI 0.27–0.96). Conclusions In our cohort, EVT did not significantly increase the likelihood of full independence or mild disability (mRS 0–2) at 3 months. However, EVT was associated with reduced mortality and a lower degree of disability among dependent patients. Conflict of interest A. Sánchez Asensio: nothing to disclose, C. Moreno López: nothing to disclose, P. González-Barquero: nothing to disclose, A.M. Iglesias Mohedano: nothing to disclose, M. Vales Montero: nothing to disclose, C. Gómez Escalonilla: nothing to disclose, P. Simal Hernández: nothing to disclose, L. Vidal Guerrero: nothing to disclose, J. Rodríguez Pardo De Donlebun: nothing to disclose, J. Alonso Maroto: nothing to disclose, S. Trillo Senin: nothing to disclose, M. Gutiérrez Sánchez De La Fuente: nothing to disclose, P. Calleja Castaño: nothing to disclose, R. Velasco Calvo: nothing to disclose, J. Carneado-Ruiz: nothing to disclose, A. Cruz Culebras: nothing to disclose, S. García Madrona: nothing to disclose, J. Masjuan Vallejo: nothing to disclose y R. Vera Lechuga: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Hospital Universitario La Paz (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínico San Carlos (ES), Hospital Universitario 12 De Octubre (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario de La Princesa (ES), Hospital Universitario Ramón y Cajal (ES), Universidad Carlos III de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 8%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.